3 CHOP Scientists Win Bayer Grants for Hemophilia Research
Published on
Dr. Paris Margaritis (right) receives award
Of four recently announced grants that the pharmaceutical company, Bayer, has awarded to U.S.-based hemophilia researchers, three grants are supporting Children’s Hospital of Philadelphia (CHOP) scientists. Now in its 15th year, the Bayer Hemophilia Awards Program (BHAP) supports innovative research and education focused on the inherited bleeding disorder.
The CHOP recipients are Paris Margaritis, DPhil; Bhavya Doshi, MD; and Manjunath Goolyam Basavaraj, PhD; all of the Division of Hematology. Bayer announced its 2017 BHAP grants, totaling $2 million to 16 recipients in eight countries, on July 11 at the International Society on Thrombosis and Hemostasis 2017 Congress in Berlin, Germany.
Dr. Margaritis has previously received two BHAP grants. The BHAP grant to Dr. Doshi is a fellowship project, while the grant to Dr. Goolyam Basavaraj is an early career investigator award. All three CHOP researchers are investigating methods to improve care for patients with hemophilia.